 |
|
Human VEGF Serum/Plasma Kit
|
| The Human VEGF Serum/Plasma Kit provides assay-specific components for the quantitative determination of both natural and recombinant human vascular endothelial growth factor (VEGF) in serum and plasma. |
|
K151BMC-3
|
Human VEGF Serum/Plasma Kit |
20 plates |
|
K151BMC-2
|
Human VEGF Serum/Plasma Kit |
5 plates |
|
A Phase I Study of the Combination of Sorafenib With Temozolomide and Radiation Therapy for the Treatment of Primary and Recurrent High-Grade Gliomas.
Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP.
|
Int J Radiat Oncol Biol Phys. |
2012 |
|
Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases.
Mathew, P., Wen, S., Morita, S., Thall, P.F.
|
J Interferon Cytokine Res. |
2011 |
|
Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism.
Cai, J., Hong, Y., Weng, C., Tan, C., Imperato-McGinley, J., Zhu, Y.S.
|
Am J Physiol Heart Circ Physiol. |
2011 |
|
Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study.
Leviton, A., Allred, E.N., Kuban, K.C., Dammann, O., Fichorova, R.N., O'Shea, T.M., Paneth, N.; for the ELGAN Study Co-Investigators.
|
Cytokine. |
2011 |
|
Persistence after birth of systemic inflammation associated with umbilical cord inflammation.
Leviton, A., Hecht, J.L., Allred, E.N., Yamamoto, H., Fichorova, R.N., Dammann, O.; for the ELGAN Study Investigators.
|
J Reprod Immunol. |
2011 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
1 plate |
| Catalog No. |
K151BMC-1 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K151BMC-1
